More importantly, this study also examined the expression of K17 in urine cytology samples from 112 patients undergoing routine bladder cancer monitoring and the study showed that K17 has sensitivity of 100% and specificity of 96% in identifying patients with recurrent urothelial cancers. Here, KRT17 is linked to urinary bladder cancer.